Pemmaraju, N., Ritchie, E., Mascarenhas, J., Fazal, S., Crowgey, E., Kim, T. (., Hamer-Maansson, J., Kalafut, T., Braunstein, E., Yacoub, A. (2025). Identification of biomarkers to predict disease progression via molecular analysis of patients (pts) with low-risk myelofibrosis (MF) enrolled in the MOST study. Blood. https://doi.org/10.1182/blood-2025-5526